This award-winning product is one of the few all-in-one home medical testing devices in Taiwan, and has already obtained MOHW medical device approval and CE certification. Most home medical testing devices on the market only test for one parameter. Our product integrates multiple functions that can test for five parameters. Different test strips can be used to take five types of readings, including blood sugar and uric acid, from minute blood samples in just a few seconds. The cholesterol test in particular needs only 15 seconds. The product has won praise for its efficiency and accuracy.

It is suitable for people with high blood pressure, high blood sugar, and high cholesterol, people needing to control their weight, people with unbalanced diets, and people having trouble controlling their metabolism to help re-balance their body. The machine’s interface is intuitive and easy to understand. It can distinguish between different test strips and comes with indicator lights. It provides a clear picture of the physical condition and readings can be transmitted in real-time to the app platform for recording and analysis to help with self-health management. The data can be linked to healthcare units as well, making it an excellent choice of tele- or home-healthcare.

A total of 34 applications were made this time, with 22 finalists. The diverse field of competitors included novel stem cell drugs, smart medical devices, portable rapid testing instruments, and innovative manufacturing techniques. The 9 national awards that were eventually given out highlighted the R&D capability and international competitiveness of the pharmaceutical biotech industry. Bioptik CEO Yi-Ling Yang said: “This award represents recognition of my company’s investment in big health. We hope our innovative R&D into medical devices as well as everyday health supplements will provide the public greater greater in health management.

The company will continue to focus on solutions that will provide the public with not only testing but also healthcare services. An early start to preventive health will improve the quality of health and create a healthy future for the people of Taiwan. The winning of a Bronze award at the National Pharmaceutical Technology & Research Development Award this time is an important milestone for Bioptik in the pharmaceutical biotech industry. It also reflects the great strides made in innovation and R&D. In the future, Bioptik will continue to focus on health through technology and work to realize our vision of a healthier tomorrow.